Tezosentan clinical trials
How each study uses tezosentan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2003 (2)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2007 | 1 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses tezosentan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Tezosentan in the Treatment of Acute Heart FailureCompletedPhase 3Idorsia Pharmaceuticals Ltd.NCT00524433Written as tezosentan
- Tezosentan in Acute Heart FailureCompletedPhase 3Idorsia Pharmaceuticals Ltd.NCT00525707Written as tezosentan
- Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart SurgeryTerminatedPhase 3Idorsia Pharmaceuticals Ltd.NCT00458276Written as tezosentan
- Tezosentan in Patients With Pulmonary Arterial HypertensionTerminatedPhase 2Idorsia Pharmaceuticals Ltd.NCT01094067Written as ACT-050089
- Tezosentan in Pulmonary Arterial HypertensionTerminatedPhase 2Idorsia Pharmaceuticals Ltd.NCT01077297Written as Tezosentan
Codes
What other systems call tezosentan · ClinicalTrials.gg INT004172
- MeSH (NLM) C120582tezosentanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 64J9J55263TEZOSENTANConfirmed FDA, NLM, Wikidata
- RxNorm 275031One source Wikidata
- Wikidata Q426203tezosentanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C97358TezosentanOne source FDA
- DrugBank DB06558One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C120582 | tezosentan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 64J9J55263 | TEZOSENTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 275031 | — | One source Wikidata |
| Wikidata | Q426203 | tezosentan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C97358 | Tezosentan | One source FDA |
| DrugBank | DB06558 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.